Cargando…
The role of stem cell transplantation in the management of Philadelphia chromosome-positive acute lymphoblastic leukemia
The concurrent administration of tyrosine kinase inhibitors (TKIs) with standard chemotherapy together with allogeneic hematopoietic stem cell transplantation (alloHSCT) has improved the outcome of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL). Although to d...
Autores principales: | Ribera, Jose-Maria, Ribera, Jordi, Genescà, Eulalia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992773/ https://www.ncbi.nlm.nih.gov/pubmed/33815735 http://dx.doi.org/10.1177/2040620718811772 |
Ejemplares similares
-
Ponatinib, chemotherapy, and transplant in adults with Philadelphia chromosome–positive acute lymphoblastic leukemia
por: Ribera, Josep-Maria, et al.
Publicado: (2022) -
Treatment of Adolescent and Young Adults with Acute Lymphoblastic Leukemia
por: Ribera, Josep-Maria, et al.
Publicado: (2014) -
Bispecific T-cell engaging antibodies in B-cell precursor acute lymphoblastic leukemias: focus on blinatumomab
por: Ribera, Jose-Maria, et al.
Publicado: (2020) -
Profile of blinatumomab and its potential in the treatment of relapsed/refractory acute lymphoblastic leukemia
por: Ribera, Josep-Maria, et al.
Publicado: (2015) -
Philadelphia chromosome-like acute lymphoblastic leukemia. Still a pending matter
por: Ribera, Josep-Maria
Publicado: (2021)